Clinical trial
The Ability of Songha Night ® to Improve Sleep in Patients With Mild to Moderate Sleep Disturbances
NCT02183714 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Ability of Songha Night ® to Improve Sleep in Patients With Mild to Moderate Sleep Disturbances
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 31, 1998
- Completion date
- Not reported
- Enrollment
- 146 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.